Camden Capital »

Cabaletta Bio shares owned by Camden Capital

Quarter-by-quarter ownership of Cabaletta Bio (CABA) shares owned by Camden Capital from 13F filings

Historical chart of Camden Capital investment in Cabaletta Bio

Tip: Access up to 7 years of quarterly data

All positions including Cabaletta Bio held by Camden Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cabaletta Bio by Camden Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $23k 10k 2.27

More positions owned by Camden Capital

NVIDIA Corporation Put Option (NVDA)
Onemain Holdings (OMF)
Citigroup Com New (C)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ge Aerospace Com New (GE)
Apple (AAPL)
Micron Technology (MU)
Ishares Tr Core S&p500 Etf (IVV)
Morgan Stanley Com New (MS)
Microsoft Corporation (MSFT)
Bank of America Corporation (BAC)
Wells Fargo & Company (WFC)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Flagstar Financial Com New (FLG)
PNC Financial Services (PNC)

View all positions for Camden Capital

Top funds holding Cabaletta Bio

Bain Capital Life Sciences Investors
Adage Capital Partners GP
Jennison Associates
T. Rowe Price Investment Management
Cormorant Asset Management
Vanguard Group
Woodline Partners
Heights Capital Management
BlackRock
Superstring Capital Management
Renaissance Technologies
Marshall Wace
Morgan Stanley
Alyeska Investment Group
Schonfeld Strategic Advisors

View all funds holding Cabaletta Bio